Skip to main content
SpringerLink
Log in

Modulation of Lupus Phenotype by Adiponectin Deficiency in Autoimmune Mouse Models

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Adiponectin is an adipocyte-derived cytokine with anti-inflammatory properties. Paradoxically, circulating adiponectin levels are increased in a number of inflammatory diseases. Thus, we sought to define the role of adiponectin deficiency in mouse models of autoimmunity. Adiponectin-deficient mice on a C57BL/6 background do not develop an autoimmune phenotype. Autoimmunity was also not observed in adiponectin-deficient mice generated on the permissive MRL background. However, adiponectin deficiency exacerbated the autoimmune phenotype of MRL-lpr mice. Compared with MRL-lpr mice, MRL-lpr.apn−/− mice displayed greater lymphadenopathy and splenomegaly, as well as increased anti-nuclear antibody and anti-dsDNA production. In addition, evaluation of the kidney revealed larger glomerular tuft size, crescent formation, increased IgG and C3 deposits, and mesangial expansion in the MRL-lpr.apn−/− mice. The effects of adiponectin deficiency on the autoimmune phenotypes were more pronounced in female versus male mice. These data show that, while adiponectin deficiency is not sufficient to confer autoimmunity, adiponectin acts as a negative modulator of the autoimmune phenotype in a murine model of lupus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939–49.

    Article  PubMed  CAS  Google Scholar 

  2. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14:561–6.

    Article  PubMed  CAS  Google Scholar 

  3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83.

    Article  PubMed  CAS  Google Scholar 

  4. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68:975–81.

    Article  PubMed  CAS  Google Scholar 

  5. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2003;301:1045–50.

    Article  PubMed  CAS  Google Scholar 

  6. Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res. 2000;32:548–54.

    Article  PubMed  CAS  Google Scholar 

  7. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50:2094–9.

    Article  PubMed  CAS  Google Scholar 

  8. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol. 2005;153:91–8.

    Article  PubMed  CAS  Google Scholar 

  9. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361:226–8.

    Article  PubMed  CAS  Google Scholar 

  10. Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006;98:1603–8.

    Article  PubMed  CAS  Google Scholar 

  11. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–7.

    Article  PubMed  CAS  Google Scholar 

  12. Atzmon G, Pollin TI, Crandall J, Tanner K, Schechter CB, Scherer PE, et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci. 2008;63:447–53.

    PubMed  Google Scholar 

  13. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731–7.

    Article  PubMed  CAS  Google Scholar 

  14. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension. 2006;47:1108–16.

    Article  PubMed  CAS  Google Scholar 

  15. Okamoto Y, Folco E, Minami M, Wara A, Feinberg M, Sukhova G, et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res. 2008;102:218–25.

    Article  PubMed  CAS  Google Scholar 

  16. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767–70.

    Article  PubMed  CAS  Google Scholar 

  17. Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007;117:375–86.

    Article  PubMed  CAS  Google Scholar 

  18. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10:1384–9.

    Article  PubMed  CAS  Google Scholar 

  19. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem. 2004;279:28670–4.

    Article  PubMed  CAS  Google Scholar 

  20. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005;11:1096–103.

    Article  PubMed  CAS  Google Scholar 

  21. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003;52:942–7.

    Article  PubMed  CAS  Google Scholar 

  22. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799–804.

    Article  PubMed  CAS  Google Scholar 

  23. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diab Care. 2003;26:1745–51.

    Article  CAS  Google Scholar 

  24. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671–4.

    Article  PubMed  CAS  Google Scholar 

  25. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96:1723–32.

    PubMed  CAS  Google Scholar 

  26. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol. 2008;121:326–30.

    Article  PubMed  CAS  Google Scholar 

  27. Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y, et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol. 2006;33:1545–52.

    PubMed  CAS  Google Scholar 

  28. Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J, et al. Adipocytokines in synovial fluid. JAMA. 2003;290:1709–10.

    Article  PubMed  Google Scholar 

  29. Furuta M, Tamai M, Hanabusa T, Yamamoto Y, Nanjo K, Sanke T. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients. Diabetes Res Clin Pract. 2006;72:302–7.

    Article  PubMed  CAS  Google Scholar 

  30. Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De Cobelli F, et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab. 2003;285:E1174–81.

    PubMed  CAS  Google Scholar 

  31. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999;5:694–7.

    Article  PubMed  CAS  Google Scholar 

  32. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243–69.

    Article  PubMed  CAS  Google Scholar 

  33. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314–7.

    Article  PubMed  CAS  Google Scholar 

  34. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390.

    Article  PubMed  CAS  Google Scholar 

  35. Aprahamian T, Bonegio RG, Richez C, Yasuda K, Chiang LK, Sato K, et al. The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. J Immunol. 2009;182:340–6.

    PubMed  CAS  Google Scholar 

  36. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746–9.

    Article  PubMed  CAS  Google Scholar 

  37. Suzuki S, Wilson-Kubalek EM, Wert D, Tsao TS, Lee DH. The oligomeric structure of high molecular weight adiponectin. FEBS Lett. 2007;581:809–14.

    Article  PubMed  CAS  Google Scholar 

  38. Peake PW, Shen Y, Walther A, Charlesworth JA. Adiponectin binds C1q and activates the classical pathway of complement. Biochem Biophys Res Commun. 2008;367:560–5.

    Article  PubMed  CAS  Google Scholar 

  39. Rovin BH, Song H, Hebert LA, Nadasdy T, Nadasdy G, Birmingham DJ, et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int. 2005;68:1825–33.

    Article  PubMed  CAS  Google Scholar 

  40. Song H, Chan J, Rovin BH. Induction of chemokine expression by adiponectin in vitro is isoform dependent. Transl Res. 2009;154:18–26.

    Article  PubMed  CAS  Google Scholar 

  41. Vadacca M, Margiotta D, Rigon A, Cacciapaglia F, Coppolino G, Amoroso A, et al. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol. 2009;36:295–7.

    Article  PubMed  CAS  Google Scholar 

  42. Bruce CR, Mertz VA, Heigenhauser GJ, Dyck DJ. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes. 2005;54:3154–60.

    Article  PubMed  CAS  Google Scholar 

  43. Panchapakesan U, Chen XM, Pollock CA. Drug insight: thiazolidinediones and diabetic nephropathy—relevance to renoprotection. Nat Clin Pract Nephrol. 2005;1:33–43.

    Article  PubMed  CAS  Google Scholar 

  44. Mullen KL, Smith AC, Junkin KA, Dyck DJ. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat fed rats. Am J Physiol Endocrinol Metab. 2007;293:E83–90.

    Article  PubMed  CAS  Google Scholar 

  45. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev. 2007;6:366–72.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Kenneth Walsh for his helpful discussions. This work was supported by National Institutes of Health Grant number K01 AR055965-02 from NIAMS to TA. JP was supported by a National Heart, Lung, and Blood Institute research training fellowship. There are no financial conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Molecular Cardiology, Whitaker Cardiovascular Institute; Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, 715 Albany Street, W611, Boston, MA, 02118, USA

    Jennifer Parker

  2. Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany Street, W611, Boston, MA, 02118, USA

    Yukihiro Takemura & Tamar Aprahamian

  3. Department of Medicine–Renal Section, Boston University School of Medicine, 650 Albany Street, 5th floor, X536, Boston, MA, 02118, USA

    Hanni Menn-Josephy, Bari Laskow & Tamar Aprahamian

Authors
  1. Jennifer Parker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanni Menn-Josephy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bari Laskow
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yukihiro Takemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tamar Aprahamian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tamar Aprahamian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parker, J., Menn-Josephy, H., Laskow, B. et al. Modulation of Lupus Phenotype by Adiponectin Deficiency in Autoimmune Mouse Models. J Clin Immunol 31, 167–173 (2011). https://doi.org/10.1007/s10875-010-9486-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-010-9486-2

Keywords

Search

Navigation